<?xml version="1.0" encoding="UTF-8"?>
<table-wrap position="float" id="tbl1">
 <label>Table 1</label>
 <caption>
  <p>Treatment options available for COVID‐19.</p>
 </caption>
 <alt-text id="alttext0020">Table 1</alt-text>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th>Compounds</th>
    <th>Virus target</th>
    <th>Functions</th>
    <th>Representative References</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td colspan="4" align="left">General treatments for viral infection</td>
   </tr>
   <tr>
    <td colspan="4" align="left">Nutritional interventions</td>
   </tr>
   <tr>
    <td align="left">Vitamin A</td>
    <td align="left">Measles virus, avian coronavirus</td>
    <td align="left">Prevention of lung infection.</td>
    <td align="left">(Semba 1999)</td>
   </tr>
   <tr>
    <td align="left">B vitamins</td>
    <td align="left">MERS‐CoV; ventilator‐induced lung injury</td>
    <td align="left">Enhance their immune system</td>
    <td align="left">(Keil, Bowen et al., 2016)</td>
   </tr>
   <tr>
    <td align="left">Vitamin C</td>
    <td align="left">Avian coronavirus; lower respiratory tract infections</td>
    <td align="left">Act as an antioxidant</td>
    <td align="left">(Atherton, Kratzing et al., 1978)</td>
   </tr>
   <tr>
    <td align="left">Vitamin D</td>
    <td align="left">Bovine coronavirus</td>
    <td align="left">Maintaining bone integrity</td>
    <td align="left">(Nonnecke, McGill et al., 2014)</td>
   </tr>
   <tr>
    <td align="left">Vitamin E</td>
    <td align="left">Coxsackievirus, bovine coronavirus</td>
    <td align="left">Reducing oxidative stress</td>
    <td align="left">(Beck, Kolbeck et al., 1994)</td>
   </tr>
   <tr>
    <td align="left">PUFA
     <xref rid="tbl1fna" ref-type="table-fn">a</xref>
    </td>
    <td align="left">Influenza virus, human immunodeficiency virus</td>
    <td align="left">Anti‐inflammatory and pro‐inflammatory effects.</td>
    <td align="left">(Morita, Kuba et al., 2013)</td>
   </tr>
   <tr>
    <td align="left">Selenium</td>
    <td align="left">Influenza virus, avian coronavirus; viral mutations</td>
    <td align="left">Defense against infectious diseases</td>
    <td align="left">(Rayman 2012)</td>
   </tr>
   <tr>
    <td align="left">Zinc</td>
    <td align="left">Measles virus, SARS‐CoV</td>
    <td align="left">Maintaining immune system</td>
    <td align="left">(Te Velthuis, van den Worm et al., 2010)</td>
   </tr>
   <tr>
    <td align="left">Iron</td>
    <td align="left">Viral mutations</td>
    <td align="left">Development of recurrent acute respiratory infections</td>
    <td align="left">(Wessling-Resnick 2018)</td>
   </tr>
   <tr>
    <td colspan="4" align="left">Immunoenhancers</td>
   </tr>
   <tr>
    <td align="left">Interferons</td>
    <td align="left">SARS‐CoV, MERS‐CoV</td>
    <td align="left">Immune response to virus infection.</td>
    <td align="left">(Momattin, Al-Ali et al., 2018)</td>
   </tr>
   <tr>
    <td align="left">Intravenous gammaglobulin</td>
    <td align="left">SARS‐CoV</td>
    <td align="left">Increase of viscosity in hypercoagulable states</td>
    <td align="left">(Lew, Kwek et al., 2003)</td>
   </tr>
   <tr>
    <td align="left">Thymosin α‐1</td>
    <td align="left">SARS‐CoV</td>
    <td align="left">Increase resistance to glucocorticoid‐induced death</td>
    <td align="left">(Baumann, Badamchian et al., 1997)</td>
   </tr>
   <tr>
    <td align="left">Thymopentin</td>
    <td align="left">hepatitis B</td>
    <td align="left">Restore antibody production</td>
    <td align="left">(Duchateau, Servais et al., 1985)</td>
   </tr>
   <tr>
    <td align="left">Levamisole</td>
    <td align="left">SARS‐CoV</td>
    <td align="left">Immunostimulant agent or immunosuppressive agent</td>
    <td align="left">(Joffe, Sukha et al., 1983)</td>
   </tr>
   <tr>
    <td align="left">Cyclosporine A</td>
    <td align="left">SARS‐CoV, avian infectious bronchitis virus</td>
    <td align="left">Treatment of autoimmune disorders</td>
    <td align="left">(Luo, Luo et al., 2004)</td>
   </tr>
   <tr>
    <td colspan="4" align="left">
     <bold>Coronavirus‐specific treatments</bold>
    </td>
   </tr>
   <tr>
    <td colspan="4" align="left">Coronavirus protease inhibitors</td>
   </tr>
   <tr>
    <td colspan="4" align="left">Chymotrypsin‐like (3C‐like) inhibitors</td>
   </tr>
   <tr>
    <td align="left">Cinanserin</td>
    <td align="left">SARS‐CoV</td>
    <td align="left">Serotonin receptor antagonist</td>
    <td align="left">(Chen, Gui et al., 2005)</td>
   </tr>
   <tr>
    <td align="left">Flavonoids</td>
    <td align="left">SARS‐CoV/MERS‐CoV</td>
    <td align="left">Antioxidant effects/antiviral abilities</td>
    <td align="left">(Diwan, Ninawe et al., 2017)</td>
   </tr>
   <tr>
    <td colspan="4" align="left">Papain‐like protease (PLP) inhibitors</td>
   </tr>
   <tr>
    <td align="left">Diarylheptanoids</td>
    <td align="left">SARS‐CoV</td>
    <td align="left">Anti-inflammatory, antioxidant, antitumor</td>
    <td align="left">(Park, Jeong et al., 2012)</td>
   </tr>
   <tr>
    <td colspan="4" align="left">Spike (S) protein‐angiotensin‐converting enzyme‐2 (ACE2) blockers</td>
   </tr>
   <tr>
    <td align="left">Human monoclonal antibody</td>
    <td align="left">SARS‐CoV</td>
    <td align="left">Treatment of many solid tumors</td>
    <td align="left">(Sui, Li et al., 2004)</td>
   </tr>
   <tr>
    <td align="left">Chloroquine</td>
    <td align="left">SARS‐CoV</td>
    <td align="left">Prevention of malaria in adults</td>
    <td align="left">(Savarino, Boelaert et al., 2003)</td>
   </tr>
   <tr>
    <td align="left">Emodin</td>
    <td align="left">SARS‐CoV</td>
    <td align="left">Pancreatic disease, inflammatory, and diabetes</td>
    <td align="left">(Vickers 2017)</td>
   </tr>
   <tr>
    <td align="left">Promazine</td>
    <td align="left">SARS‐CoV</td>
    <td align="left">Using in paranoid and manic-depressive conditions,</td>
    <td align="left">(Cauwenberghs, Feijge et al., 2006)</td>
   </tr>
   <tr>
    <td align="left">Nicotianamine</td>
    <td align="left">SARS‐CoV</td>
    <td align="left">To reduce the infection</td>
    <td align="left">(Cauwenberghs, Feijge et al., 2006)</td>
   </tr>
   <tr>
    <td colspan="4" align="left">
     <bold>Antiviral treatments</bold>
    </td>
   </tr>
   <tr>
    <td align="left">Ribavirin</td>
    <td align="left">SARS‐CoV</td>
    <td align="left">Treatment of hepatitis C</td>
    <td align="left">(Ksiazek, Erdman et al., 2003)</td>
   </tr>
   <tr>
    <td align="left">(LPV)
     <xref rid="tbl1fnb" ref-type="table-fn">b</xref>/(RTV)
     <xref rid="tbl1fnC" ref-type="table-fn">c</xref> (Kaletra)
    </td>
    <td align="left">MERS‐CoV</td>
    <td align="left">Treatment of HIV infection</td>
    <td align="left">(Tsang and Zhong 2003)</td>
   </tr>
   <tr>
    <td align="left">Remdesivir</td>
    <td align="left">SARS‐CoV/MERS‐CoV</td>
    <td align="left">Treatment of Ebola virus disease and Marburg virus</td>
    <td align="left">(Yamamoto, Yang et al., 2004)</td>
   </tr>
   <tr>
    <td align="left">Nelfinavir</td>
    <td align="left">SARS‐CoV</td>
    <td align="left">Treatment of HIV</td>
    <td align="left">(Mohanasundaram and Sekhar 2018)</td>
   </tr>
   <tr>
    <td align="left">Arbidol</td>
    <td align="left">SARS‐CoV</td>
    <td align="left">Treatment for influenza infection</td>
    <td align="left">(Khamitov, Loginova et al., 2008)</td>
   </tr>
   <tr>
    <td align="left">Nitric oxide</td>
    <td align="left">SARS‐CoV</td>
    <td align="left">Treatment of inflammatory airway disease</td>
    <td align="left">(Robbins and Grisham 1997)</td>
   </tr>
  </tbody>
 </table>
 <table-wrap-foot>
  <fn id="tbl1fna">
   <label>a</label>
   <p id="ntpara0010">Omega‐3 polyunsaturated fatty acid.</p>
  </fn>
 </table-wrap-foot>
 <table-wrap-foot>
  <fn id="tbl1fnb">
   <label>b</label>
   <p id="ntpara0015">Lopinavir.</p>
  </fn>
 </table-wrap-foot>
 <table-wrap-foot>
  <fn id="tbl1fnC">
   <label>C</label>
   <p id="ntpara0020">Ritonavir.</p>
  </fn>
 </table-wrap-foot>
</table-wrap>
